Phesi is a life sciences technology company that applies artificial intelligence and patient-centric clinical data science to help pharmaceutical and biotechnology organizations plan and execute clinical development. Its Trial Accelerator™ platform draws on a large database of real-world clinical trial information to generate insights for more informed decisions throughout drug development.

Phesi’s services support protocol design and optimization, patient population profiling, selection of countries and investigator sites, trial performance assessment, and strategic development planning. The company also creates Digital Patient Profiles, Digital Twins, and Digital Trial Arms, which can help model diseases and potential patient outcomes and provide evidence for external control arms. Its tools are designed to improve population accuracy and diversity, reduce patient burden, and help teams identify promising trial designs while limiting costly amendments or failures. Phesi also offers trial health checks and rescue support, as well as data services, resources, and case studies. Its solutions cover a range of disease indications, including rare diseases, and are intended to help life sciences teams accelerate clinical development and commercialization.